acute urticaria. Urticaria, unspecified
Conditions
Interventions
Intervention 1: The control group was treated with cetirizine syrup (Citirizine Tolid Daro Tehran Company), 5cc per day for 15 days. Intervention 2: the first group received 10% Plantago major aqueous
Treatment - Drugs
The control group was treated with cetirizine syrup (Citirizine Tolid Daro Tehran Company), 5cc per day for 15 days.
the first group received 10% Plantago major aqueous extract, 5cc per day for 15 days
Sponsors
Ancient Medicine Faculty,Vice chancellor for research, Shahid Beheshti University of Medical Science
Eligibility
Sex/Gender
All
Age
10 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 10 to 70 years old patients; no history of autoimmune or immunodeficiency disease; negative drug history; willingness to participate in the study Exclusion criteria: received antihistaminic drugs, or combination of corticosteroids a month before the trial; pregnancy; previous allergy to Antihistamines or any of the ingredients in the herbal medicinal products; unwillingness to participate in the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of itching, drug resistance, and side effects. Timepoint: days 3 and 15. Method of measurement: visiting a dermatologist at the clinic.;Number of urticarial lesions. Timepoint: every day. Method of measurement: Asking the patient.;Amount of itching, drug resistance, and side effects. Timepoint: days 9 and 6. Method of measurement: Asking the patient.;Satisfaction of treatment. Timepoint: At the end of the follow ups. Method of measurement: Asking the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohammad Ali Yazdian
Ancient Medicine Faculty, Shahid Beheshti University of Medical Sciences
Outcome results
None listed